摘要
目的探讨促肝细胞生长素对改善先天性胆管扩张症病人术后并发症发生的关系。方法回顾性分析我院十年来78例先天性胆管扩张症患者的临床资料,使之分为促肝细胞生长素组(A组)和非促肝细胞生长素组(B组),比较手术前后各项指标有无差异。结果A组术后并发症的发生率显著低于B组(4.3%VS15.5%P<0.05),另外术后肝功能恢复的时间亦明显较B组短(22.23天VS39.42天,P<0.01)。结论应用促肝细胞生长素治疗,有助于改善肝功能,提高先天性胆管扩张症病人对手术的耐受性,降低术后并发症的发生率。
Objective To under-stand relationship between pHGF and the post-operative com-plications of congenital dilatation of the bileduct jaundice patients. Methods Retrospective indicating the clinical information of congenital dilatation of the bileduct jaundice patients （78）, classified into A group treated by pHGF and B group untreated by pHGF. Comparing the occurrence rate of pest-complications, and the recevery time of hepatic function, respectively. Results Distinct variation will be find： average rate is in A group 4.3%, in B group 15.5% （p〈0.05）, average time in A group is 22.23 days in B group 39.42 days （p〈0.01）. Conclusions Obviously treatment by pHGF to congenital dilatation of the bileduct jaundice patients can improve hepatic function, upgrade endurance to operation and reduce occurrence rate of pest-complications.
出处
《海南医学》
CAS
2007年第3期44-44,38,共2页
Hainan Medical Journal
关键词
促肝细胞生长素
先天性胆管扩张症
Hepatocyte Growth-promoting Factors HGF congenital dilatation of the bileduct Jaundice
